$Effect of dapagliflozin in paroxysmal atrial fibrillation combined with heart failure with preserved ejection fraction: a randomized controlled trial$

Effect of dapagliflozin in paroxysmal atrial fibrillation combined with heart failure with preserved ejection fraction: a randomized controlled trial

ObjectiveTo explore the efficacy and safety of dapagliflozin in patients with paroxysmal atrial fibrillation (PAF) combined with heart failure with preserved ejection fraction (HFpEF). MethodsA total of 120 patients with PAF combined with HFpEF treated at Jinshan Hospital of Fudan University from Ju...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoyu LIAN, Fei PENG, Hui GONG, Juying QIAN
Format:	Article
Language:	English
Published:	Shanghai Chinese Clinical Medicine Press Co., Ltd. 2025-06-01
Series:	Zhongguo Linchuang Yixue
Subjects:	dapagliflozin heart failure with preserved ejection fraction paroxysmal atrial fibrillation kansas city cardiomyopathy questionnaire-total symptom score
Online Access:	https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250497
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

Importance of non‐cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction
by: Yasuhiro Hamatani, et al.
Published: (2025-02-01)

Hearing the Vagus Nerve’s Rhythm in Patients with Paroxysmal Atrial Fibrillation
by: A. A. Nechepurenko, et al.
Published: (2020-07-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

STRUCTURAL AND ELECTROPHYSIOLOGICAL PREDICTORS OF A PAROXYSM OF ATRIAL FIBRILLATION
by: B. G. Iskenderov, et al.
Published: (2001-08-01)

COMPARISON OF TREATMENT EFFICACY IN PAROXYSMAL ATRIAL FIBRILLATION
by: V. G. Tregubov, et al.
Published: (2017-04-01)

Echocardiographic assessment of left atrial structural and functional changes after catheter ablation in paroxysmal atrial fibrillation with preserved ejection fraction
by: Qi Zhang, et al.
Published: (2025-08-01)

Prevalence and echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction
by: K. G. Adamyan, et al.
Published: (2016-02-01)

Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study
by: J. Anusha, et al.
Published: (2025-07-01)

Heart rate variability and trans-esophageal atrial stimulation data in predicting recurrent atrial fibrillation paroxysms
by: T. V. Setyn, et al.
Published: (2007-12-01)

Distribution Patterns of Paroxysmal Atrial Fibrillation Triggers and Catheter Ablation Success Rates
by: Dongsheng Zhao, et al.
Published: (2025-03-01)

Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice
by: Gerhild Euler, et al.
Published: (2025-07-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

The HFA‐PEFF score and outcomes in patients with sick sinus syndrome and preserved ejection fraction after pacemaker implantation
by: Hironobu Sumiyoshi, et al.
Published: (2025-06-01)

Machine-learning model for predicting left atrial thrombus in patients with paroxysmal atrial fibrillation
by: Wanli Xiong, et al.
Published: (2025-06-01)

Mechanisms of paroxysmal atrial fibrillation in patients with sick sinus syndrome
by: S. Yu. Ivanov, et al.
Published: (2004-08-01)

Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model
by: Wei-Chieh Lee, et al.
Published: (2024-11-01)

Prolonged ECG monitoring: indications for paroxysmal atrial fibrillation diagnostics in coronary heart disease patients
by: S. Yu. Ivanov, et al.
Published: (2006-06-01)

CARDIOVERSION WITH BI- AND MONOPHASE DEFIBRILLATORS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION
by: V. A. Lusov, et al.
Published: (2010-02-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

Pulsed‐Field Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation: A Systematic Review and Meta‐Analysis
by: Inês Martins Esteves, et al.
Published: (2025-08-01)

Radiofrequency or cryoablation or medical therapy for paroxysmal atrial fibrillation: An indirect comparison of effectiveness
by: Roberto Brunoro, et al.
Published: (2025-04-01)

The impact of left atrial voltage abnormality on ablation outcomes in paroxysmal atrial fibrillation and its pre-procedural predictors: an observational retrospective study
by: Dongsheng Zhao, et al.
Published: (2025-07-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
by: P. P. Bidzilya, et al.
Published: (2021-11-01)

Safety and efficacy of catheter ablation in atrial fibrillation patients with heart failure with preserved ejection fraction
by: Songbing Long, et al.
Published: (2025-01-01)

Association between plasma trimethylamine N-oxide level and atrial fibrillation
by: YANG Wentao, ZHAO Qing, LI Xiangdong, WANG Yutang, LIU Wei
Published: (2025-04-01)

Atorvastain effectiveness in patients with heart failure, preserved systolic function, and paroxysmal atrial fibrillation
by: E. S. Kozlova, et al.
Published: (2009-12-01)

Optimized workflow for paroxysmal atrial fibrillation ablation using very high power short duration
by: Lorenzo Gigli, et al.
Published: (2025-02-01)

Rare genetic variants involved in increased risk of paroxysmal atrial fibrillation in a Japanese population
by: Kanji Tabata, et al.
Published: (2025-04-01)

Laboratory changes and prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction, excess weight and concomitant atrial fibrillation
by: P. P. Bidzilya, et al.
Published: (2023-01-01)

Structural and functional changes of the heart in chronic heart failure with preserved left ventricular ejection fraction with excess body weight depending on the presence and form of atrial fibrillation
by: P. P. Bidzilya, et al.
Published: (2021-07-01)

Corrigendum: Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts
by: Julian Wolfes, et al.
Published: (2025-02-01)

Differentiating Left Atrial Pressure Responses in Paroxysmal and Persistent Atrial Fibrillation: Implications for Diagnosing Heart Failure With Preserved Ejection Fraction and Managing Atrial Fibrillation
by: Jong Sung Park, et al.
Published: (2024-09-01)

Prognostic Value of Spontaneous Potential in Left Atrial Posterior Wall Isolation and Radiofrequency Ablation for Non-Paroxysmal Atrial Fibrillation
by: Chen ZY, et al.
Published: (2025-07-01)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective
by: Malte Kuniss, et al.
Published: (2024-11-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case–control study
by: Wei Li, et al.
Published: (2025-01-01)

SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper
by: João Pedro Ferreira, et al.
Published: (2025-08-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)